PROK · NASDAQ
ProKidney (PROK) Stock Price & Fundamentals
ProKidney (PROK) closed at $349.19 on Oct 9, 2026, down 1.29% from the previous close of $353.76.
Share price, past year
1Y +26.68%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $349.19 |
| Sep 30, 2026 | $350.82 |
| Aug 31, 2026 | $364.02 |
| Jul 31, 2026 | $352.19 |
| Jun 30, 2026 | $329.20 |
| May 29, 2026 | $310.09 |
| Apr 30, 2026 | $309.95 |
| Mar 31, 2026 | $292.82 |
| Feb 27, 2026 | $291.01 |
| Jan 30, 2026 | $278.78 |
| Dec 31, 2025 | $264.09 |
| Nov 28, 2025 | $277.71 |
| Oct 31, 2025 | $280.81 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $818.00K
- Net income (TTM)
- −$84.16M
- Shares outstanding
- —
- Dividend yield
- —
- 52-week range
- $258.75 – $365.77
Financials
ProKidney reported revenue of $893.00K for fiscal 2025, up 1,075.00% from fiscal 2024.
ProKidney reported a net loss of $68.99M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $893.00K | +1,075.0% | −$68.99M | −7,725.2% | — | −$135.31M |
| FY2024ended Dec 31, 2024 | $76.00K | — | −$61.19M | −80,507.9% | — | −$155.86M |
| FY2023ended Dec 31, 2023 | $0.00 | — | −$35.47M | — | — | −$124.27M |
| FY2022ended Dec 31, 2022 | $0.00 | — | — | — | −$0.23 | −$78.94M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $150.00K | −$28.42M | — |
| Q1 FY2026ended Mar 31, 2026 | $226.00K | −$20.04M | — |
| Q4 FY2025ended Dec 31, 2025 | $225.00K | −$19.23M | — |
| Q3 FY2025ended Sep 30, 2025 | $217.00K | −$16.47M | — |
| Q2 FY2025ended Jun 30, 2025 | $221.00K | −$16.55M | — |
| Q1 FY2025ended Mar 31, 2025 | $230.00K | −$16.73M | — |
| Q4 FY2024ended Dec 31, 2024 | $76.00K | −$21.28M | — |
| Q3 FY2024ended Sep 30, 2024 | $0.00 | −$17.91M | — |
Company profile
- Name
- ProKidney Corp.
- Ticker
- PROK
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 2000 Frontis Plaza Blvd., Suite 250, Winston-Salem, NC 27103
- Incorporated in
- E9
- Fiscal year ends
- December
- SEC CIK
- 0001850270
Recent SEC filings
- Aug 10, 2026
- Aug 10, 2026
- May 29, 2026
- May 15, 2026
- May 15, 2026
- Mar 18, 2026
- Mar 18, 2026
- Feb 2, 2026
Frequently asked questions
What is ProKidney's stock price?
ProKidney (PROK) closed at $349.19 on Oct 9, 2026, down 1.29% from the previous close of $353.76.
How much revenue does ProKidney make?
ProKidney reported revenue of $893.00K for fiscal 2025, up 1,075.00% from fiscal 2024.
Does ProKidney pay a dividend?
ProKidney's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from ProKidney Corp.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures